Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Maȷor Bleeding [Coronary Heart Disease]

ConclusionsGDF‐15 at 1 month after an ACS is related to the risk of bleeding during DAPT and provides additional information on the bleeding risk beyond baseline GDF‐15 levels. GDF‐15 levels may therefore be useful as part of decision support concerning long‐term antithrombotic treatment in patients post‐ACS.Clinical Trial RegistrationURL: http://www.clinicaltrials.gov. Unique identifier: NCT00391872.

Source: JAHA:Journal of the American Heart Association - April 14, 2017 Category: Cardiology Authors: Lindholm, D., Hagstrom, E., James, S. K., Becker, R. C., Cannon, C. P., Himmelmann, A., Katus, H. A., Maurer, G., Lopez-Sendon, J. L., Steg, P. G., Storey, R. F., Siegbahn, A., Wallentin, L. Tags: Biomarkers Original Research Source Type: research